
Dr. Reddy’s secures early win in Novo Nordisk’s ‘Ozempic’ infringement claim
On May 29, the Delhi High Court recorded Dr. Reddy’s undertaking not to sell its Ozempic-like drug in India, amid Novo Nordisk’s ongoing patent suit. Dr. Reddy’s noted it holds a manufacturing licence but reserves the right to export to non-patent jurisdictions—an argument opposed by Novo...